Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Acoustic Neuroma - Otolaryngology - Lecture Slides, Slides of Otorhinolaryngology

Acoustic Neuroma, Gold Standard for Diagnosis, Sensitivity of Abr, Robinette and Bauch, Probability of Acoustic, Calculated Cost of Mri, Unilateral Persistent Tinnitus. This is one of lectures in Otolaryngology also know as "Ear, nose and throat" course. Every aspect of this course has been explained, each topic related to this particular field of surgery is explained in this series of lecture.

Typology: Slides

2011/2012

Uploaded on 12/13/2012

shahbaz_34
shahbaz_34 🇮🇳

4.6

(17)

148 documents

1 / 10

Related documents


Partial preview of the text

Download Acoustic Neuroma - Otolaryngology - Lecture Slides and more Slides Otorhinolaryngology in PDF only on Docsity! Acoustic Neuroma • 12 per million per year • MRI can detect tumors as small as 3mm • Gold standard for diagnosis is MRI of IAC’s with gadolinium • Test cost at this institution is $3200 Docsity.com Acoustic Neuroma • ABR – Alternative to MRI for diagnosis – MRI generally 5 times more expensive than ABR – Decreased sensitivity – Cost at this institution is $500 Docsity.com Acoustic Neuroma • Used probability of acoustic in each group as (30%, 5%, 1%) • Sensitivity of detecting tumors with ABR based on size (100% large, 93% medium, 82% small) • Used PPV of 12% in ABR Docsity.com Acoustic Neuroma • Calculated cost of MRI for patients in each group • Calculated cost of ABR, and MRI for all ABR’s suggestive of acoustic neuroma • Calculated cost difference of two groups based on risk from history and physical • Calculated number acoustic neuromas missed if first screened with ABR Docsity.com Acoustic Neuroma • High risk - $40,000, no missed tumors • Intermediate risk - $900,000, clinician would miss 4 tumors in 900 patients screened • Low risk – $1.7 million, 1 tumor missed out of 1600 screened • Authors recommended clinical decision making with consideration of cost savings in intermediate to low risk groups Docsity.com
Docsity logo



Copyright © 2024 Ladybird Srl - Via Leonardo da Vinci 16, 10126, Torino, Italy - VAT 10816460017 - All rights reserved